Envista Holdings Corporation (NVST)
Envista Q1 Earnings Call Highlights
Envista NYSE: NVST reported a strong start to 2026, with management citing broad-based growth across its major dental businesses, margin expansion and continued investment in new products and commercial capabilities.
Envista (NVST) International Revenue Performance Explored
Explore Envista's (NVST) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Why Envista (NVST) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Envista: Spotlight On Q1 Outperformance And New Growth Drivers
My existing 'buy' rating for Envista is left unchanged following my evaluation of its results and outlook. NVST's 1Q2026 earnings beat consensus by 15%, thanks to a defensive dental market and the company's own cost reduction efforts. The company's high-teens EPS growth guidance for the full year is well-supported by new product launches and synergies relating to its latest M&A.
Envista Holdings Corporation (NVST) Q1 2026 Earnings Call Transcript
Envista Holdings Corporation (NVST) Q1 2026 Earnings Call Transcript
Here's What Key Metrics Tell Us About Envista (NVST) Q1 Earnings
The headline numbers for Envista (NVST) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Envista (NVST) Surpasses Q1 Earnings and Revenue Estimates
Envista (NVST) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.24 per share a year ago.
Here's Why Envista (NVST) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why You Should Add NVST Stock to Your Portfolio Right Now
Envista Holdings Corporation's NVST strategic priorities position it for robust growth in the upcoming quarters. The company is positioned to benefit from favorable long-term dental industry trends.
Envista Stock Up 42.5% in a Year: What's Driving It?
Envista NVST shares have climbed 42.5% over the past year, showcasing impressive momentum. The stock has outpaced the industry's 22.5% decline and the S&P 500 composite's 16.6% gain.
NVST or SYK: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?
Best Value Stocks to Buy for March 16th
OPRX, NVST and STRT made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 16, 2026.
